Northern Trust’s Esperion Therapeutics ESPR Stock Holding History

Northern Trust’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.76M	Buy	2,104,008 +108,302	+5%	+$343K	﹤0.01%	2382
2025 Q4	$7.38M	Buy	1,995,706 +147,269	+8%	+$476K	﹤0.01%	2246
2025 Q3	$4.9M	Buy	1,848,437 +64,311	+4%	+$124K	﹤0.01%	2518
2025 Q2	$1.76M	Buy	1,784,126 +245,118	+16%	+$245K	﹤0.01%	3065
2025 Q1	$2.22M	Sell	1,539,008 -1,076	-0.1%	-$1.98K	﹤0.01%	2870
2024 Q4	$3.39M	Buy	1,540,084 +65,662	+4%	+$153K	﹤0.01%	2739
2024 Q3	$2.43M	Buy	1,474,422 +1,069,384	+264%	+$2.16M	﹤0.01%	2878
2024 Q2	$899K	Buy	405,038 +96,361	+31%	+$227K	﹤0.01%	3297
2024 Q1	$827K	Buy	308,677 +72,084	+30%	+$175K	﹤0.01%	3392
2023 Q4	$707K	Buy	236,593 +7,883	+3%	+$10.2K	﹤0.01%	3427
2023 Q3	$224K	Buy	228,710 +67,480	+42%	+$97.6K	﹤0.01%	3767
2023 Q2	$224K	Sell	161,230 -515,092	-76%	-$719K	﹤0.01%	3784
2023 Q1	$1.08M	Buy	676,322 +11,239	+2%	+$58K	﹤0.01%	3196
2022 Q4	$4.14M	Buy	665,083 +83,075	+14%	+$594K	﹤0.01%	2600
2022 Q3	$3.9M	Buy	582,008 +14,312	+3%	+$98.3K	﹤0.01%	2639
2022 Q2	$3.61M	Buy	567,696 +41,856	+8%	+$237K	﹤0.01%	2714
2022 Q1	$2.44M	Buy	525,840 +188,683	+56%	+$809K	﹤0.01%	3003
2021 Q4	$1.69M	Buy	337,157 +42,315	+14%	+$339K	﹤0.01%	3309
2021 Q3	$3.55M	Sell	294,842 -18,046	-6%	-$263K	﹤0.01%	2952
2021 Q2	$6.62M	Buy	312,888 +7,963	+3%	+$192K	﹤0.01%	2656
2021 Q1	$8.55M	Sell	304,925 -20,319	-6%	-$599K	﹤0.01%	2396
2020 Q4	$8.46M	Sell	325,244 -12,823	-4%	-$384K	﹤0.01%	2362
2020 Q3	$12.6M	Sell	338,067 -14,655	-4%	-$580K	﹤0.01%	1958
2020 Q2	$18.1M	Buy	352,722 +38,789	+12%	+$1.62M	﹤0.01%	1703
2020 Q1	$9.9M	Buy	313,933 +3,571	+1%	+$188K	﹤0.01%	1875
2019 Q4	$18.5M	Sell	310,362 -7,680	-2%	-$345K	﹤0.01%	1784
2019 Q3	$11.7M	Buy	318,042 +25,320	+9%	+$1M	﹤0.01%	2045
2019 Q2	$13.6M	Buy	292,722 +2,689	+0.9%	+$126K	﹤0.01%	1951
2019 Q1	$11.6M	Buy	290,033 +2,206	+0.8%	+$99K	﹤0.01%	2050
2018 Q4	$13.2M	Sell	287,827 -338,812	-54%	-$16.3M	﹤0.01%	1887
2018 Q3	$27.8M	Buy	626,639 +36,535	+6%	+$1.68M	0.01%	1510
2018 Q2	$23.1M	Buy	590,104 +10,702	+2%	+$541K	0.01%	1672
2018 Q1	$41.9M	Buy	579,402 +5,025	+0.9%	+$369K	0.01%	1114
2017 Q4	$37.8M	Sell	574,377 -3,540	-0.6%	-$191K	0.01%	1221
2017 Q3	$29M	Buy	577,917 +143,004	+33%	+$6.9M	0.01%	1424
2017 Q2	$20.1M	Sell	434,913 -88,697	-17%	-$3.26M	0.01%	1667
2017 Q1	$18.5M	Buy	523,610 +17,098	+3%	+$392K	0.01%	1680
2016 Q4	$6.34M	Buy	506,512 +2,137	+0.4%	+$25.4K	﹤0.01%	2387
2016 Q3	$6.99M	Buy	504,375 +168,489	+50%	+$1.91M	﹤0.01%	2296
2016 Q2	$3.32M	Buy	335,886 +144,373	+75%	+$2.39M	﹤0.01%	2726
2016 Q1	$3.45M	Buy	191,513 +6,361	+3%	+$102K	﹤0.01%	2653
2015 Q4	$4.12M	Buy	185,152 +4,728	+3%	+$119K	﹤0.01%	2570
2015 Q3	$4.26M	Buy	180,424 +78,379	+77%	+$4.92M	﹤0.01%	2541
2015 Q2	$8.34M	Buy	102,045 +30,811	+43%	+$3.02M	﹤0.01%	2182
2015 Q1	$6.6M	Buy	71,234 +4,020	+6%	+$259K	﹤0.01%	2334
2014 Q4	$2.72M	Buy	67,214 +16,372	+32%	+$501K	﹤0.01%	2901
2014 Q3	$1.24M	Sell	50,842 -1,692	-3%	-$26.9K	﹤0.01%	3341
2014 Q2	$833K	Sell	52,534 -6,444	-11%	-$93.1K	﹤0.01%	3464
2014 Q1	$891K	Sell	58,978 -5,020	-8%	-$77.9K	﹤0.01%	3425
2013 Q4	$879K	Buy	63,998 +43,483	+212%	+$633K	﹤0.01%	3414
2013 Q3	$387K	Buy	+20,515	New	+$345K	﹤0.01%	3501